Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.6 USD | -1.20% | +2.28% | +19.10% |
04:14pm | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
08:52am | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.10% | 332B | |
+25.92% | 661B | |
+26.74% | 566B | |
-6.78% | 352B | |
+3.16% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.39% | 145B | |
-10.99% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Starts Phase 3 Clinical Trial of Potential Lung Cancer Combination Therapy